JP2024527142A - リキッドバイオプシーにおける変異検出の方法 - Google Patents

リキッドバイオプシーにおける変異検出の方法 Download PDF

Info

Publication number
JP2024527142A
JP2024527142A JP2024506585A JP2024506585A JP2024527142A JP 2024527142 A JP2024527142 A JP 2024527142A JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024527142 A JP2024527142 A JP 2024527142A
Authority
JP
Japan
Prior art keywords
dna
mutation
group
fragments
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527142A5 (cg-RX-API-DMAC7.html
Inventor
レーズ・ジャン・フランソワ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OncoDNA SA
Original Assignee
OncoDNA SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OncoDNA SA filed Critical OncoDNA SA
Publication of JP2024527142A publication Critical patent/JP2024527142A/ja
Publication of JP2024527142A5 publication Critical patent/JP2024527142A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/20—Screening of libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/204—Modifications characterised by specific length of the oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Library & Information Science (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2024506585A 2021-08-04 2022-08-02 リキッドバイオプシーにおける変異検出の方法 Pending JP2024527142A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189685.7A EP4130293A1 (en) 2021-08-04 2021-08-04 Method of mutation detection in a liquid biopsy
EP21189685.7 2021-08-04
PCT/EP2022/071749 WO2023012186A1 (en) 2021-08-04 2022-08-02 Method of mutation detection in a liquid biopsy

Publications (2)

Publication Number Publication Date
JP2024527142A true JP2024527142A (ja) 2024-07-19
JP2024527142A5 JP2024527142A5 (cg-RX-API-DMAC7.html) 2025-08-06

Family

ID=77226600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506585A Pending JP2024527142A (ja) 2021-08-04 2022-08-02 リキッドバイオプシーにおける変異検出の方法

Country Status (4)

Country Link
US (1) US20240327924A1 (cg-RX-API-DMAC7.html)
EP (2) EP4130293A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527142A (cg-RX-API-DMAC7.html)
WO (1) WO2023012186A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120048346B (zh) * 2025-01-24 2026-02-27 中科金辰生物科技(合肥)有限公司 一种肿瘤特异性基因突变和甲基化联合生物信息学分析方法及系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018512048A (ja) * 2015-02-10 2018-05-10 ザ チャイニーズ ユニバーシティ オブ ホンコン 癌スクリーニング及び胎児分析のための変異検出
US20210102199A1 (en) * 2019-10-08 2021-04-08 Illumina, Inc. Fragment size characterization of cell-free dna mutations from clonal hematopoiesis
JP2021516962A (ja) * 2018-03-06 2021-07-15 キャンサー・リサーチ・テクノロジー・リミテッドCancer Research Technology Limited バリアント検出の改善

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11342047B2 (en) 2017-04-21 2022-05-24 Illumina, Inc. Using cell-free DNA fragment size to detect tumor-associated variant
GB201819134D0 (en) * 2018-11-23 2019-01-09 Cancer Research Tech Ltd Improvements in variant detection
GB201818159D0 (en) 2018-11-07 2018-12-19 Cancer Research Tech Ltd Enhanced detection of target dna by fragment size analysis
US11929148B2 (en) 2019-03-13 2024-03-12 Grail, Llc Systems and methods for enriching for cancer-derived fragments using fragment size

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018512048A (ja) * 2015-02-10 2018-05-10 ザ チャイニーズ ユニバーシティ オブ ホンコン 癌スクリーニング及び胎児分析のための変異検出
JP2021516962A (ja) * 2018-03-06 2021-07-15 キャンサー・リサーチ・テクノロジー・リミテッドCancer Research Technology Limited バリアント検出の改善
US20210102199A1 (en) * 2019-10-08 2021-04-08 Illumina, Inc. Fragment size characterization of cell-free dna mutations from clonal hematopoiesis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARASS, FRANCESCO ET AL.: "Fragment size analysis may distinguish clonal hematopoiesis from tumor-derived mutations in cell-fre", CLINICAL CHEMISTRY, vol. 66, no. 4, JPN6026031399, 2020, pages 616 - 618, ISSN: 0005918203 *

Also Published As

Publication number Publication date
EP4130293A1 (en) 2023-02-08
WO2023012186A1 (en) 2023-02-09
US20240327924A1 (en) 2024-10-03
EP4381092A1 (en) 2024-06-12

Similar Documents

Publication Publication Date Title
US12191000B2 (en) Systems and methods for classifying patients with respect to multiple cancer classes
TWI874039B (zh) 利用核酸長度範圍於非侵入性產前檢測及癌症偵測
US20190292607A1 (en) Using test patterns of chromosomal regions in plasma dna for detecting cancer
US20210104297A1 (en) Systems and methods for determining tumor fraction in cell-free nucleic acid
US20200219587A1 (en) Systems and methods for using fragment lengths as a predictor of cancer
EP3801623A1 (en) Convolutional neural network systems and methods for data classification
US20240249798A1 (en) Systems and methods for enriching for cancer-derived fragments using fragment size
US20210065842A1 (en) Systems and methods for determining tumor fraction
US20200385813A1 (en) Systems and methods for estimating cell source fractions using methylation information
CN112086129A (zh) 预测肿瘤组织cfDNA的方法及系统
KR20190085667A (ko) 무세포 dna를 포함하는 샘플에서 순환 종양 dna를 검출하는 방법 및 그 용도
JP2024545610A (ja) 疾患分類のための長い無細胞dna分子を用いた分子分析
CN113544288A (zh) 用于预测肝癌复发的dna甲基化标志物及其用途
US20240327924A1 (en) Method of mutation detection in a liquid biopsy
JP2026509730A (ja) 白血球混入検出
WO2025061097A9 (en) Uses of cell-free dna fragmentation patterns associated with epigenetic modifications
US20250079005A1 (en) Eccdna remnants as a cancer biomarker
TW202609789A (zh) 衰老之片段化模式
Ensminger Early Cancer Detection in Hereditary Breast and Ovarian Cancer Syndrome with Cell-Free DNA
HK40004786B (en) A ctdna-based gene detection device, storage medium and computer system
HK40004786A (en) A ctdna-based gene detection device, storage medium and computer system
CN111094594A (zh) 产生复数候选探针和鉴定哺乳动物中细胞类型的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250729

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250729

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260716

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260728